step teens semaglutide Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial step teens semaglutide Oral Lowers

Redness and sensitivity caused by barrier stress

A survey by benefits consultant Mercer found 49% of large employers covered GLP-1 medications for obesity in 2025

Potential BenefitsWhen used under medical supervision, Ipamorelin therapy may offer several benefits: Body Composition: Promotes an increase in lean muscle mass and enhances fat metabolism (lipolysis), aiding in weight management

Increased Energy Expenditure: GLP-1 RAs may activate sympathetic pathways in the hypothalamus (specifically the dorsomedial and ventromedial nuclei) that increase thermogenic activity in brown adipose tissue (BAT), contributing to increased energy expenditure and weight loss